Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma (Q36887663)
Jump to navigation
Jump to search
scientific article published on May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma |
scientific article published on May 2015 |
Statements
1 reference
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma (English)
1 reference
Shiv K Gupta
1 reference
Sani H Kizilbash
1 reference
Brett L Carlson
1 reference
Ann C Mladek
1 reference
Felix Boakye-Agyeman
1 reference
Katrina K Bakken
1 reference
Jenny L Pokorny
1 reference
Mark A Schroeder
1 reference
Paul A Decker
1 reference
Ling Cen
1 reference
Jeanette E Eckel-Passow
1 reference
Gobinda Sarkar
1 reference
Karla V Ballman
1 reference
Joel M Reid
1 reference
Robert B Jenkins
1 reference
Roeland G Verhaak
1 reference
Erik P Sulman
1 reference
Gaspar J Kitange
1 reference
Jann N Sarkaria
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference